Patent Assignment
Reel/Frame 038281/0055
Assignment of Assignor's Interest
Recorded: 2016-04-14
Pages: 9
Assignors
ECKELMAN, BRENDAN P.
Executed: 2016-03-31
TIMMER, JOHN C.
Executed: 2016-03-08
DEVERAUX, QUINN
Executed: 2016-03-08
Assignee
INHIBRX LP
11099 N. TORREY PINES ROAD, SUITE 280, LA JOLLA, CALIFORNIA, 92037
Covered Property
(1)
Non-Immunogenic Single Domain Antibodies
Patent:
10,526,397 →
Application:
15/003,234 →
Publication:
US 2016/0207981
PCT:
PCT/US2016/014296 ↗
Related Assignments
(10)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 15, 2017
From: INHIBRX BIOPHARMA, LLC
To: INHIBRX LP
Reel/Frame 044133/0835 →
Merger and Change of Name
May 22, 2018
From: INHIBRX LP; TENIUM THERAPEUTICS, INC.
To: INHIBRX, INC.
Reel/Frame 046215/0084 →
Intellectual Property Security Agreement
Feb 28, 2022
From: INHIBRX, INC.
To: OXFORD FINANCE LLC
Reel/Frame 059262/0780 →
Assignment of Assignor's Interest
May 23, 2024
From: INHIBRX, LP
To: INHIBRX, INC.
Reel/Frame 067508/0149 →
Assignment of Assignor's Interest
May 23, 2024
From: INHIBRX BIOPHARMA, LLC
To: INHIBRX, LP
Reel/Frame 067508/0157 →
Release of Security Interest
Jun 3, 2024
From: OXFORD FINANCE LLC, AS COLLATERAL AGENT
To: INHIBRX, INC.
Reel/Frame 067606/0247 →
Assignment of Assignor's Interest
Jun 10, 2024
From: INHIBRX, INC.
To: INHIBRX BIOSCIENCES, INC.
Reel/Frame 067680/0831 →
Assignment of Assignor's Interest
Jun 10, 2024
From: INHIBRX, INC.
To: INHIBRX BIOSCIENCES, INC.
Reel/Frame 067680/0770 →
Correction by Declaration Erroneously Filed Against Reel 038281/Frame 0055.
Jun 24, 2024
From: INHIBRX, LP
To: INHIBRX, LP
Reel/Frame 068309/0664 →
Security Interest
Jan 14, 2025
From: INHIBRX BIOSCIENCES, INC.
To: OXFORD FINANCE LLC; OXFORD FINANCE LLC
Reel/Frame 069894/0045 →